-

Valtris Completes Divestiture of Champlor Renewables to Avril

Highly strategic transaction advances Valtris’ focus on its core specialty additives business

INDEPENDENCE, Ohio--(BUSINESS WIRE)--Valtris Specialty Chemicals, a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the successful closing of the previously announced sale of its Champlor Renewables business located in Baleycourt, France to Avril Industrie.

Champlor Renewables specializes in rapeseed crushing, refining, and biodiesel production. Located in the heart of one of France’s main rapeseed-growing regions, the business processes approximately 400,000 tons of seeds per year.

“We are pleased to complete this transaction with Avril,” said Mike McGaugh, CEO, Valtris Specialty Chemicals. “The closing represents a key milestone in our efforts to focus on the core of our portfolio as a global leader in specialty performance additives. This divestiture simplifies our portfolio and operations, and strengthens our ability to continue to invest in growth and innovation as we advance our mission to be a world class partner to our customers.”

“I would like to thank the Champlor Renewables team for its commitment. We are pleased to have found a strategic fit for the business, which is in the best interests of our employees, customers and suppliers. At the same time, we are excited to build on our strong heritage and 75-year history of leadership in our core polymer end-use applications.”

Valtris will continue to own and operate its specialty additives business co-located at the Baleycourt site, which provides value-added sustainable solutions to polymer end-use applications in a variety of industries such as coatings, adhesives, sealants and functional fluids.

Lazard served as a financial advisor to Valtris, and Latham & Watkins LLP acted as legal counsel.

ABOUT VALTRIS

Valtris Specialty Chemicals, headquartered in Independence, Ohio, is a global leader in specialty performance additives, offering innovative sustainable solutions and products to customers around the world. With strong technical and regulatory expertise and best-in-class formulation capabilities, Valtris develops products that provide essential performance properties to polymer end-use applications in the coatings, adhesives and sealants, pharmaceuticals, oil and gas, lubricant, and personal care industries. The company operates seven manufacturing locations and employs approximately 470 people across North America, Europe and Asia. For more information, please visit www.valtris.com.

Contacts

Jeremy Milner
Gregory
jmilner@gregoryagency.com
(401) 862-9422

SK Capital


Release Summary
VALTRIS COMPLETES DIVESTITURE OF CHAMPLOR RENEWABLES TO AVRIL
Release Versions

Contacts

Jeremy Milner
Gregory
jmilner@gregoryagency.com
(401) 862-9422

More News From SK Capital

Valtris Specialty Chemicals Announces New Chief Human Resources Officer

INDEPENDENCE, Ohio--(BUSINESS WIRE)--Valtris Specialty Chemicals, a leading global manufacturer of a comprehensive portfolio of specialty additives, announced today the appointment of Clint Shephard as the company’s new Chief Human Resources Officer. Mr. Shephard will play a key role in leading the company’s global talent strategy. Mr. Shephard will be based in the company’s new office in Midland, Michigan. Mr. Shephard most recently served as Senior Director of Human Resources at Myers Industr...

SK Capital Partners Completes the Sale of Phoenix Flavors & Fragrances to Turpaz Industries

NORWOOD, N.J.--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the material sciences, specialty ingredients, and life sciences sectors, announced today that it has completed the sale of Phoenix Flavors & Fragrances Inc. (“Phoenix” or the “Company”) to Turpaz Industries Ltd (TLV: TRPZ), a global developer, manufacturer, and marketer of specialty fragrance, flavor, and natural ingredient solutions for consumer and in...

SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG

NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry....
Back to Newsroom